Given the similarity in inflammatory pathways between GPP and psoriasis vulgaris, it is plausible to hypothesize that GPP, through the same mechanisms involving IL-17 and IL-36, might similarly enhance the risk of cerebrovascular events. Here, IL17A is linked to psoriasis vulgaris.